Alkermes
ALKS
$24.44
Share price
-0.85%
Change (1 day)
-19.90%
Change (1 year)
Categories
Earnings for Alkermes (ALKS)
Earnings in 2023 (TTM): $0.44 B
According to Alkermes's latest financial reports the company's current earnings (TTM) are $0.44 B. an increase over its 2022 earnings that were of -$0.16 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Alkermes from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | $0.44 B | -388.18% |
| 2022 | -$0.16 B | 449.24% |
| 2021 | -$28.09 M | -68.04% |
| 2020 | -$87.88 M | -52.1% |
| 2019 | -$0.19 B | 64.49% |
| 2018 | -$0.12 B | -15.04% |
| 2017 | -$0.14 B | -34.2% |
| 2016 | -$0.2 B | -5.34% |
| 2015 | -$0.22 B | 35084.97% |
| 2014 | -$0.6 M | |
| 2012 | $7.42 M | -117.81% |
| 2011 | -$41.69 M | -12.69% |
| 2010 | -$47.74 M | 94.3% |
| 2009 | -$24.57 M | -117.7% |
| 2008 | $0.13 B | 622.63% |
| 2007 | $19.21 M | |
| 2004 | -$75.98 M | -14.48% |
| 2003 | -$88.84 M | 11.88% |
| 2002 | -$79.41 M | 39.65% |
| 2001 | -$56.86 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | 3,717.78% | 🇺🇸 USA |
 Novartis NVS | $9.43 B | 2,023.04% | 🇨🇭 Switzerland |
 Pfizer PFE | $3.26 B | 634.90% | 🇺🇸 USA |
 Sanofi SNY | $8.39 B | 1,788.50% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $8.44 B | 1,798.54% | 🇺🇸 USA |
 AstraZeneca AZN | $8.49 B | 1,810.92% | 🇬🇧 UK |
 Zogenix ZGNX | -$0.22 B | -147.70% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -$0.27 B | -159.35% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $0.40 B | -8.90% | 🇮🇱 Israel |